|
Market Closed -
Nasdaq
21:00:00 23/10/2026 BST
|
5-day change | 1st Jan Change | ||
| 3.890 USD | -1.27% |
|
+15.77% | -32.58% |
| 10-21 | Unicycive Therapeutics Shares Rise After FDA Accepts Resubmitted NDA | DJ |
| 10-21 | Unicycive Therapeutics Announces FDA Acceptance of Oxylanthanum Carbonate New Drug Application Resubmission | CI |
| Market Cap | 108M 96.76M 89.39M 81.01M 152M 10.29B 154M 1.08B 426M 5.39B 407M 398M 16.99B | P/E 2026 * |
-3.07x | P/E 2027 * | 2.39x |
|---|---|---|---|---|---|
| Enterprise Value | 108M 96.76M 89.39M 81.01M 152M 10.29B 154M 1.08B 426M 5.39B 407M 398M 16.99B | EV / Sales 2026 * |
79.1x | EV / Sales 2027 * | 0.78x |
| Free-Float |
97.74% | Yield 2026 * |
-
| Yield 2027 * | 53.5% |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| UNCY | Delayed | |
CBOE
| UNCY | Real-time |
Last Transcript: Unicycive Therapeutics, Inc.
| 1 day | -1.27% | ||
| 1 week | +15.77% | ||
| Current month | -17.15% | ||
| 1 month | -19.13% | ||
| 3 months | -27.96% | ||
| 6 months | -46.64% | ||
| Current year | -32.58% |
| 1 week | 3.36 |  | 4.18 |
| 1 month | 3.35 | | 4.81 |
| Current year | 3.35 | | 8.74 |
| 1 year | 3.35 | | 8.74 |
| 3 years | 2.02 | | 18.18 |
| 5 years | 2.02 | | 31.3 |
| 10 years | 2.02 | | 87.3 |
| Manager | Title | Age | Since |
|---|---|---|---|
Shalabh Gupta
CEO | Chief Executive Officer | 53 | 17/08/2016 |
John Townsend
DFI | Director of Finance/CFO | 64 | 28/02/2021 |
Guru Reddy
CTO | Chief Tech/Sci/R&D Officer | - | 31/12/2021 |
| Director | Title | Age | Since |
|---|---|---|---|
Shalabh Gupta
CHM | Chairman | 53 | 17/08/2016 |
Sandeep Laumas
BRD | Director/Board Member | 58 | 31/12/2017 |
| Director/Board Member | 58 | 05/09/2023 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 14/05/26 | Free | Chief Operating Officer | 169,500 | 0.6716% | ||
| 14/05/26 | Free | Executive/Senior Manager | 169,500 | 0.6716% | ||
| 14/05/26 | Free | Chief Financial Officer | 169,500 | 0.6716% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.27% | +15.77% | -24.17% | -46.77% | 108M | |
| +2.41% | +0.29% | +39.41% | +72.14% | 64.69B | |
| -0.15% | +7.50% | +11.42% | +71.27% | 54.78B | |
| +0.57% | +4.60% | +7.71% | +90.93% | 53.49B | |
| +0.37% | +4.67% | +26.68% | +49.64% | 45.98B | |
| -1.21% | +2.32% | +21.50% | +118.33% | 42.94B | |
| -0.37% | +5.07% | +243.23% | +789.58% | 40.08B | |
| +0.05% | +0.21% | +18.06% | +48.50% | 33.52B | |
| +1.19% | -4.98% | +26.31% | -0.76% | 23.97B | |
| -0.38% | +5.68% | +38.39% | +28.35% | 23.67B | |
| Average | +0.12% | +3.75% | +40.85% | +122.12% | 38.32B | |
| Weighted average by Cap. | +0.39% | +2.73% | +46.00% | +142.78% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.37M 1.22M 1.13M 1.02M 1.92M 130M 1.95M 13.6M 5.38M 68.14M 5.14M 5.03M 215M | 139M 124M 115M 104M 194M 13.19B 198M 1.38B 546M 6.91B 522M 510M 21.79B |
| Net income | -35.38M -31.6M -29.19M -26.45M -49.49M -3.36B -50.31M -351M -139M -1.76B -133M -130M -5.55B | 51.53M 46.01M 42.51M 38.52M 72.07M 4.89B 73.26M 512M 203M 2.56B 193M 189M 8.08B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 23/10/26 | US$3.890 | -1.27% | 1,212,426 |
| 22/10/26 | US$3.940 | +1.81% | 742,888 |
| 21/10/26 | US$3.870 | +1.84% | 1,439,444 |
| 20/10/26 | US$3.800 | +8.26% | 1,207,934 |
| 19/10/26 | US$3.510 | +4.46% | 1,126,561 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- UNCY Stock
Select your edition
All financial news and data tailored to specific country editions
